CARMAT announced the opening of its second production facility in Bois-d'Arcy, in the immediate vicinity of the Company's first production facility. The works have now been completed, and the entire facility has been reviewed by the notified body DEKRA, which in mid-November 2023 approved it for the production of the Aeson® total artificial heart. This 1,500 m2 building, which meets the highest medical device production standards, will enable CARMAT to significantly increase its capacity in terms of: assembly of the electronic parts of the Aeson® heart, microbiological testing of the product and the manufacturing process, receiving and checking incoming components, storage and shipping.

Combined with the extension of the clean room which is currently being completed in the "BDA1" facility, the opening of the "BDA2" facility will enable the Company to reach an annual production capacity of 500 hearts by early 2024, as planned.